{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:04:14Z","timestamp":1792058654429,"version":"4.4.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The combination of pyrimethamine and sulfadiazine is the standard care in cases of congenital toxoplasmosis. However, therapy with these drugs is associated with severe and sometimes life-threatening side effects. The investigation of phytotherapeutic alternatives to treat parasitic diseases without acute toxicity is essential for the advancement of current therapeutic practices. The present study investigates the antiparasitic effects of oleoresins from different species of<jats:italic>Copaifera<\/jats:italic>genus against<jats:italic>T. gondii<\/jats:italic>. Oleoresins from<jats:italic>C. reticulata<\/jats:italic>,<jats:italic>C. duckei<\/jats:italic>,<jats:italic>C. paupera,<\/jats:italic>and<jats:italic>C. pubiflora<\/jats:italic>were used to treat human trophoblastic cells (BeWo cells) and human villous explants infected with<jats:italic>T. gondii.<\/jats:italic>Our results demonstrated that oleoresins were able to reduce<jats:italic>T. gondii<\/jats:italic>intracellular proliferation, adhesion, and invasion. We observed an irreversible concentration-dependent antiparasitic action in infected BeWo cells, as well as parasite cell cycle arrest in the S\/M phase. The oleoresins altered the host cell environment by modulation of ROS, IL-6, and MIF production in BeWo cells. Also,<jats:italic>Copaifera<\/jats:italic>oleoresins reduced parasite replication and TNF-\u03b1 release in villous explants. Anti-<jats:italic>T. gondii<\/jats:italic>effects triggered by the oleoresins are associated with immunomodulation of the host cells, as well as, direct action on parasites.<\/jats:p>","DOI":"10.1038\/s41598-020-72230-0","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T10:03:22Z","timestamp":1600250602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Copaifera spp. oleoresins impair Toxoplasma gondii infection in both human trophoblastic cells and human placental explants"],"prefix":"10.1038","volume":"10","author":[{"given":"Samuel Cota","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Cristina","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e1dia Evelyn","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Monteiro","family":"Rosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio Alves","family":"Aguila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Ricardo","family":"Ambr\u00f3sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Cassio Sola","family":"Veneziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo Kenupp","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Jos\u00e9 Barbosa","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Henrique Gomes","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bellisa","family":"de Freitas Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa Am\u00e1lia Vieira","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"key":"72230_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijpara.2008.10.001","volume":"39","author":"HP Beck","year":"2009","unstructured":"Beck, H. P. et al. Molecular approaches to diversity of populations of apicomplexan parasites. Int. J. Parasitol. 39, 175\u2013189. https:\/\/doi.org\/10.1016\/j.ijpara.2008.10.001 (2009).","journal-title":"Int. J. Parasitol."},{"key":"72230_CR2","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","volume":"39","author":"G Pappas","year":"2009","unstructured":"Pappas, G., Roussos, N. & Falagas, M. E. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int. J. Parasitol. 39, 1385\u20131394. https:\/\/doi.org\/10.1016\/j.ijpara.2009.04.003 (2009).","journal-title":"Int. J. Parasitol."},{"key":"72230_CR3","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/s0140-6736(04)16412-x","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya, J. G. & Liesenfeld, O. Toxoplasmosis. Lancet (London, England) 363, 1965\u20131976. https:\/\/doi.org\/10.1016\/s0140-6736(04)16412-x (2004).","journal-title":"Lancet (London, England)"},{"key":"72230_CR4","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.ijpara.2008.03.007","volume":"38","author":"JP Dubey","year":"2008","unstructured":"Dubey, J. P. & Jones, J. L. Toxoplasma gondii infection in humans and animals in the United States. Int. J. Parasitol. 38, 1257\u20131278. https:\/\/doi.org\/10.1016\/j.ijpara.2008.03.007 (2008).","journal-title":"Int. J. Parasitol."},{"key":"72230_CR5","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1017\/s0031182012000765","volume":"139","author":"JP Dubey","year":"2012","unstructured":"Dubey, J. P., Lago, E. G., Gennari, S. M., Su, C. & Jones, J. L. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 139, 1375\u20131424. https:\/\/doi.org\/10.1017\/s0031182012000765 (2012).","journal-title":"Parasitology"},{"key":"72230_CR6","doi-asserted-by":"publisher","first-page":"e2043","DOI":"10.1371\/journal.pntd.0002043","volume":"7","author":"G Minbaeva","year":"2013","unstructured":"Minbaeva, G. et al. Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis. PLoS Negl. Trop. Dis. 7, e2043. https:\/\/doi.org\/10.1371\/journal.pntd.0002043 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"72230_CR7","doi-asserted-by":"publisher","first-page":"e030472","DOI":"10.1136\/bmjopen-2019-030472","volume":"9","author":"JJ Bigna","year":"2019","unstructured":"Bigna, J. J. & Tochie, J. N. Global, regional and national estimates of Toxoplasma gondii seroprevalence in pregnant women: a protocol for a systematic review and modelling analysis. BMJ Open 9, e030472. https:\/\/doi.org\/10.1136\/bmjopen-2019-030472 (2019).","journal-title":"BMJ Open"},{"key":"72230_CR8","doi-asserted-by":"publisher","first-page":"e0005222","DOI":"10.1371\/journal.pntd.0005222","volume":"11","author":"F Peyron","year":"2017","unstructured":"Peyron, F. et al. Congenital Toxoplasmosis in France and the United States: one parasite, two diverging approaches. PLoS Negl. Trop. Dis. 11, e0005222. https:\/\/doi.org\/10.1371\/journal.pntd.0005222 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"72230_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s10393-019-01405-7","volume":"16","author":"AA Aguirre","year":"2019","unstructured":"Aguirre, A. A. et al. The one health approach to Toxoplasmosis: epidemiology, control, and prevention strategies. EcoHealth 16, 378\u2013390. https:\/\/doi.org\/10.1007\/s10393-019-01405-7 (2019).","journal-title":"EcoHealth"},{"key":"72230_CR10","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/s0140-6736(98)08220-8","volume":"353","author":"D Dunn","year":"1999","unstructured":"Dunn, D. et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet (London, England) 353, 1829\u20131833. https:\/\/doi.org\/10.1016\/s0140-6736(98)08220-8 (1999).","journal-title":"Lancet (London, England)"},{"key":"72230_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/cmr.05013-11","volume":"25","author":"F Robert-Gangneux","year":"2012","unstructured":"Robert-Gangneux, F. & Darde, M. L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin. Microbiol. Rev. 25, 264\u2013296. https:\/\/doi.org\/10.1128\/cmr.05013-11 (2012).","journal-title":"Clin. Microbiol. Rev."},{"key":"72230_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jogoh.2017.12.003","volume":"47","author":"S Fallahi","year":"2018","unstructured":"Fallahi, S., Rostami, A., Nourollahpour Shiadeh, M., Behniafar, H. & Paktinat, S. An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection. J. Gynecol. Obst. Hum. Reprod. 47, 133\u2013140. https:\/\/doi.org\/10.1016\/j.jogoh.2017.12.003 (2018).","journal-title":"J. Gynecol. Obst. Hum. Reprod."},{"key":"72230_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.actatropica.2011.10.018","volume":"121","author":"Y Carlier","year":"2012","unstructured":"Carlier, Y., Truyens, C., Deloron, P. & Peyron, F. Congenital parasitic infections: a review. Acta Trop. 121, 55\u201370. https:\/\/doi.org\/10.1016\/j.actatropica.2011.10.018 (2012).","journal-title":"Acta Trop."},{"key":"72230_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1017\/s1466252315000183","volume":"16","author":"HM Wyrosdick","year":"2015","unstructured":"Wyrosdick, H. M. & Schaefer, J. J. Toxoplasma gondii: history and diagnostic test development. Anim. Health Res. reviews 16, 150\u2013162. https:\/\/doi.org\/10.1017\/s1466252315000183 (2015).","journal-title":"Anim. Health Res. reviews"},{"key":"72230_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.pt.2011.09.005","volume":"27","author":"F Robert-Gangneux","year":"2011","unstructured":"Robert-Gangneux, F. et al. The placenta: a main role in congenital toxoplasmosis?. Trends Parasitol. 27, 530\u2013536. https:\/\/doi.org\/10.1016\/j.pt.2011.09.005 (2011).","journal-title":"Trends Parasitol."},{"key":"72230_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000351","author":"M Cortina-Borja","year":"2010","unstructured":"Cortina-Borja, M. et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. https:\/\/doi.org\/10.1371\/journal.pmed.1000351 (2010).","journal-title":"PLoS Med."},{"key":"72230_CR17","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1016\/j.ijid.2012.01.016","volume":"16","author":"L Campello Porto","year":"2012","unstructured":"Campello Porto, L. & Duarte, E. C. Association between the risk of congenital toxoplasmosis and the classification of toxoplasmosis in pregnant women and prenatal treatment in Brazil, 1994\u20132009. Int. J. Infect. Dis. IJID Off Publ. Int. Soc. Infect. Dis. 16, e480\u2013e486. https:\/\/doi.org\/10.1016\/j.ijid.2012.01.016 (2012).","journal-title":"Int. J. Infect. Dis. IJID Off Publ. Int. Soc. Infect. Dis."},{"key":"72230_CR18","doi-asserted-by":"publisher","first-page":"e0138204","DOI":"10.1371\/journal.pone.0138204","volume":"10","author":"HX Wei","year":"2015","unstructured":"Wei, H. X., Wei, S. S., Lindsay, D. S. & Peng, H. J. A systematic review and meta-analysis of the efficacy of anti-Toxoplasma gondii medicines in humans. PLoS ONE 10, e0138204. https:\/\/doi.org\/10.1371\/journal.pone.0138204 (2015).","journal-title":"PLoS ONE"},{"key":"72230_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.puhe.2007.08.009","volume":"122","author":"HM Elsheikha","year":"2008","unstructured":"Elsheikha, H. M. Congenital toxoplasmosis: priorities for further health promotion action. Public health 122, 335\u2013353. https:\/\/doi.org\/10.1016\/j.puhe.2007.08.009 (2008).","journal-title":"Public health"},{"key":"72230_CR20","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1447-0756.2010.01459.x","volume":"37","author":"S Tamaru","year":"2011","unstructured":"Tamaru, S. et al. Fetal therapy of severe symptomatic toxoplasmosis using azithromycin. J. Obst. Gynaecol. Res. 37, 953\u2013957. https:\/\/doi.org\/10.1111\/j.1447-0756.2010.01459.x (2011).","journal-title":"J. Obst. Gynaecol. Res."},{"key":"72230_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1086\/590149","volume":"47","author":"JG Montoya","year":"2008","unstructured":"Montoya, J. G. & Remington, J. S. Management of Toxoplasma gondii infection during pregnancy. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 47, 554\u2013566. https:\/\/doi.org\/10.1086\/590149 (2008).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"72230_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s1359-6446(04)03308-2","volume":"10","author":"AC Anderson","year":"2005","unstructured":"Anderson, A. C. Targeting DHFR in parasitic protozoa. Drug Discov. Today 10, 121\u2013128. https:\/\/doi.org\/10.1016\/s1359-6446(04)03308-2 (2005).","journal-title":"Drug Discov. Today"},{"key":"72230_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/00365549850160963","volume":"30","author":"I Villena","year":"1998","unstructured":"Villena, I. et al. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand. J. Infect. Dis. 30, 295\u2013300. https:\/\/doi.org\/10.1080\/00365549850160963 (1998).","journal-title":"Scand. J. Infect. Dis."},{"key":"72230_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1051\/parasite\/2013020","volume":"20","author":"C Doliwa","year":"2013","unstructured":"Doliwa, C. et al. Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters. Parasite (Paris, France) 20, 19. https:\/\/doi.org\/10.1051\/parasite\/2013020 (2013).","journal-title":"Parasite (Paris, France)"},{"key":"72230_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/(sici)1520-6866(2000)20:2<65::aid-tcm2>3.0.co;2-k","volume":"20","author":"KK Vijayalaxmi","year":"2000","unstructured":"Vijayalaxmi, K. K. & Vishalakshi, M. Evaluation of the genotoxic effects of pyrimethamine, an antimalarial drug, in the in vivo mouse. Teratog. Carcinog. Mutagen. 20, 65\u201371. https:\/\/doi.org\/10.1002\/(sici)1520-6866(2000)20:2%3c65::aid-tcm2%3e3.0.co;2-k (2000).","journal-title":"Teratog. Carcinog. Mutagen."},{"key":"72230_CR26","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/aje\/153.10.961","volume":"153","author":"S Hernandez-Diaz","year":"2001","unstructured":"Hernandez-Diaz, S., Werler, M. M., Walker, A. M. & Mitchell, A. A. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am. J. Epidemiol. 153, 961\u2013968. https:\/\/doi.org\/10.1093\/aje\/153.10.961 (2001).","journal-title":"Am. J. Epidemiol."},{"key":"72230_CR27","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fmicb.2014.00484","volume":"5","author":"HS Oz","year":"2014","unstructured":"Oz, H. S. Toxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone. Front. Microbiol. 5, 484. https:\/\/doi.org\/10.3389\/fmicb.2014.00484 (2014).","journal-title":"Front. Microbiol."},{"key":"72230_CR28","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.placenta.2009.08.002","volume":"30","author":"IN Costa","year":"2009","unstructured":"Costa, I. N. et al. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae). Placenta 30, 884\u2013890. https:\/\/doi.org\/10.1016\/j.placenta.2009.08.002 (2009).","journal-title":"Placenta"},{"key":"72230_CR29","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.placenta.2011.08.012","volume":"32","author":"PS Franco","year":"2011","unstructured":"Franco, P. S. et al. Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection. Placenta 32, 838\u2013844. https:\/\/doi.org\/10.1016\/j.placenta.2011.08.012 (2011).","journal-title":"Placenta"},{"key":"72230_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1479-5876-12-132","volume":"12","author":"LS Castro-Filice","year":"2014","unstructured":"Castro-Filice, L. S. et al. Azithromycin is able to control Toxoplasma gondii infection in human villous explants. J. Transl. Med. 12, 132. https:\/\/doi.org\/10.1186\/1479-5876-12-132 (2014).","journal-title":"J. Transl. Med."},{"key":"72230_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12929-019-0503-3","volume":"26","author":"PS Franco","year":"2019","unstructured":"Franco, P. S. et al. Brazilian strains of Toxoplasma gondii are controlled by azithromycin and modulate cytokine production in human placental explants. J. Biomed. Sci. 26, 10. https:\/\/doi.org\/10.1186\/s12929-019-0503-3 (2019).","journal-title":"J. Biomed. Sci."},{"key":"72230_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.vetpar.2011.12.039","volume":"187","author":"BF Barbosa","year":"2012","unstructured":"Barbosa, B. F. et al. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models. Vet. Parasitol. 187, 44\u201352. https:\/\/doi.org\/10.1016\/j.vetpar.2011.12.039 (2012).","journal-title":"Vet. Parasitol."},{"key":"72230_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fcimb.2017.00340","volume":"7","author":"RJ da Silva","year":"2017","unstructured":"da Silva, R. J. et al. Enrofloxacin and toltrazuril are able to reduce Toxoplasma gondii growth in human BeWo trophoblastic cells and villous explants from human third trimester pregnancy. Front. Cell. Infect. Microbiol. 7, 340. https:\/\/doi.org\/10.3389\/fcimb.2017.00340 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"72230_CR34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1128\/mmbr.64.3.607-623.2000","volume":"64","author":"MW Black","year":"2000","unstructured":"Black, M. W. & Boothroyd, J. C. Lytic cycle of Toxoplasma gondii. Microbiol. Mol. Biol. Rev. MMBR 64, 607\u2013623. https:\/\/doi.org\/10.1128\/mmbr.64.3.607-623.2000 (2000).","journal-title":"Microbiol. Mol. Biol. Rev. MMBR"},{"key":"72230_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrmicro1800","volume":"6","author":"JC Boothroyd","year":"2008","unstructured":"Boothroyd, J. C. & Dubremetz, J. F. Kiss and spit: the dual roles of Toxoplasma rhoptries. Nat. Rev. Microbiol. 6, 79\u201388. https:\/\/doi.org\/10.1038\/nrmicro1800 (2008).","journal-title":"Nat. Rev. Microbiol."},{"key":"72230_CR36","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2147\/ijn.s122178","volume":"12","author":"OS Adeyemi","year":"2017","unstructured":"Adeyemi, O. S., Murata, Y., Sugi, T. & Kato, K. Inorganic nanoparticles kill Toxoplasma gondii via changes in redox status and mitochondrial membrane potential. Int. J. Nanomed. 12, 1647\u20131661. https:\/\/doi.org\/10.2147\/ijn.s122178 (2017).","journal-title":"Int. J. Nanomed."},{"key":"72230_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1051\/parasite\/2000071003","volume":"7","author":"F Benoit-Vical","year":"2000","unstructured":"Benoit-Vical, F., Santillana-Hayat, M., Kone-Bamba, D., Mallie, M. & Derouin, F. Anti-toxoplasma activity of vegetal extracts used in West African traditional medicine. Parasite (Paris, France) 7, 3\u20137. https:\/\/doi.org\/10.1051\/parasite\/2000071003 (2000).","journal-title":"Parasite (Paris, France)"},{"key":"72230_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0304-4017(03)00154-7","volume":"116","author":"HJ Youn","year":"2003","unstructured":"Youn, H. J., Lakritz, J., Kim, D. Y., Rottinghaus, G. E. & Marsh, A. E. Anti-protozoal efficacy of medicinal herb extracts against Toxoplasma gondii and Neospora caninum. Vet. Parasitol. 116, 7\u201314. https:\/\/doi.org\/10.1016\/s0304-4017(03)00154-7 (2003).","journal-title":"Vet. Parasitol."},{"key":"72230_CR39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijantimicag.2008.04.012","volume":"32","author":"KM Choi","year":"2008","unstructured":"Choi, K. M., Gang, J. & Yun, J. Anti-Toxoplasma gondii RH strain activity of herbal extracts used in traditional medicine. Int. J. Antimicrob. Agents 32, 360\u2013362. https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.04.012 (2008).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"72230_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1472-6882-12-91","volume":"12","author":"N Kavitha","year":"2012","unstructured":"Kavitha, N., Noordin, R., Chan, K. L. & Sasidharan, S. In vitro anti-Toxoplasma gondii activity of root extract\/fractions of Eurycoma longifolia Jack. BMC Complement. Altern. Med. 12, 91. https:\/\/doi.org\/10.1186\/1472-6882-12-91 (2012).","journal-title":"BMC Complement. Altern. Med."},{"key":"72230_CR41","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.apjtm.2016.06.012","volume":"9","author":"I Al Nasr","year":"2016","unstructured":"Al Nasr, I., Ahmed, F., Pullishery, F., El-Ashram, S. & Ramaiah, V. V. Toxoplasmosis and anti-Toxoplasma effects of medicinal plant extracts\u2014a mini-review. Asian Pac. J. Trop. Med. 9, 730\u2013734. https:\/\/doi.org\/10.1016\/j.apjtm.2016.06.012 (2016).","journal-title":"Asian Pac. J. Trop. Med."},{"key":"72230_CR42","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1128\/aac.49.8.3463-3467.2005","volume":"49","author":"EJ Mui","year":"2005","unstructured":"Mui, E. J. et al. Triazine inhibits Toxoplasma gondii tachyzoites in vitro and in vivo. Antimicrob. Agents Chemother. 49, 3463\u20133467. https:\/\/doi.org\/10.1128\/aac.49.8.3463-3467.2005 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"72230_CR43","first-page":"965","volume":"38","author":"NA Al-Zanbagi","year":"2008","unstructured":"Al-Zanbagi, N. A. & Zelai, N. T. Two methods for attenuating Toxoplasma gondii tachyzoites RH strain by using ethanol extract of Curcuma longa. J. Egypt. Soc. Parasitol. 38, 965\u2013976 (2008).","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"72230_CR44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/2230-8229.96997","volume":"16","author":"NA Al-Zanbagi","year":"2009","unstructured":"Al-Zanbagi, N. A. In vivo effect of some home spices extracts on the Toxoplasma gondii tachyzoites. J. Fam. Commun. Med. 16, 59\u201365 (2009).","journal-title":"J. Fam. Commun. Med."},{"key":"72230_CR45","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.phymed.2011.06.008","volume":"18","author":"T Efferth","year":"2011","unstructured":"Efferth, T., Herrmann, F., Tahrani, A. & Wink, M. Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin. Phytomed. Int. J. Phytother. Phytopharmacol. 18, 959\u2013969. https:\/\/doi.org\/10.1016\/j.phymed.2011.06.008 (2011).","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."},{"key":"72230_CR46","doi-asserted-by":"publisher","first-page":"e0156116","DOI":"10.1371\/journal.pone.0156116","volume":"11","author":"A Leesombun","year":"2016","unstructured":"Leesombun, A., Boonmasawai, S., Shimoda, N. & Nishikawa, Y. Effects of extracts from thai piperaceae plants against infection with Toxoplasma gondii. PLoS ONE 11, e0156116. https:\/\/doi.org\/10.1371\/journal.pone.0156116 (2016).","journal-title":"PLoS ONE"},{"key":"72230_CR47","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1139\/cjpp-2016-0039","volume":"94","author":"M Sharif","year":"2016","unstructured":"Sharif, M. et al. The efficacy of herbal medicines against Toxoplasma gondii during the last 3 decades: a systematic review. Can. J. Physiol. Pharmacol. 94, 1237\u20131248. https:\/\/doi.org\/10.1139\/cjpp-2016-0039 (2016).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"72230_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1051\/parasite\/2018014","volume":"25","author":"M Degbe","year":"2018","unstructured":"Degbe, M. et al. Extracts of tectona grandis and vernonia amygdalina have anti-toxoplasma and pro-inflammatory properties in vitro. Parasite (Paris, France) 25, 11. https:\/\/doi.org\/10.1051\/parasite\/2018014 (2018).","journal-title":"Parasite (Paris, France)"},{"key":"72230_CR49","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1055\/s-0032-1328712","volume":"79","author":"E Izumi","year":"2013","unstructured":"Izumi, E., Ueda-Nakamura, T., Veiga-Junior, V. F. & Nakamura, C. V. Toxicity of oleoresins from the genus Copaifera in Trypanosoma cruzi: a comparative study. Planta Med. 79, 952\u2013958. https:\/\/doi.org\/10.1055\/s-0032-1328712 (2013).","journal-title":"Planta Med."},{"key":"72230_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.phymed.2016.11.021","volume":"24","author":"GA de Souza","year":"2017","unstructured":"de Souza, G. A. et al. In vitro and in vivo antimalarial potential of oleoresin obtained from Copaifera reticulata Ducke (Fabaceae) in the Brazilian Amazon rainforest. Phytomed. Int. J. Phytother. Phytopharmacol. 24, 111\u2013118. https:\/\/doi.org\/10.1016\/j.phymed.2016.11.021 (2017).","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."},{"key":"72230_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13756-018-0307-3","volume":"7","author":"RGL Vieira","year":"2018","unstructured":"Vieira, R. G. L. et al. In vitro studies of the antibacterial activity of Copaifera spp. oleoresins, sodium hypochlorite, and peracetic acid against clinical and environmental isolates recovered from a hemodialysis unit. Antimicrob. Resist. Infect. Control 7, 14. https:\/\/doi.org\/10.1186\/s13756-018-0307-3 (2018).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"72230_CR52","doi-asserted-by":"publisher","first-page":"9781724","DOI":"10.1155\/2018\/9781724","volume":"2018","author":"IA Rodrigues","year":"2018","unstructured":"Rodrigues, I. A. & Ramos, A. S. Development of nanoemulsions to enhance the antileishmanial activity of copaifera paupera oleoresins. BioMed Res. Int. 2018, 9781724. https:\/\/doi.org\/10.1155\/2018\/9781724 (2018).","journal-title":"BioMed Res. Int."},{"key":"72230_CR53","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.biopha.2018.04.164","volume":"103","author":"D Kian","year":"2018","unstructured":"Kian, D. et al. Trypanocidal activity of copaiba oil and kaurenoic acid does not depend on macrophage killing machinery. Biomed. Pharmacother. Biomed. Pharmacother. 103, 1294\u20131301. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.164 (2018).","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"72230_CR54","doi-asserted-by":"publisher","first-page":"e8143","DOI":"10.1371\/journal.pone.0008143","volume":"4","author":"S Ravindran","year":"2009","unstructured":"Ravindran, S., Lodoen, M. B., Verhelst, S. H., Bogyo, M. & Boothroyd, J. C. 4-Bromophenacyl bromide specifically inhibits rhoptry secretion during Toxoplasma invasion. PLoS ONE 4, e8143. https:\/\/doi.org\/10.1371\/journal.pone.0008143 (2009).","journal-title":"PLoS ONE"},{"key":"72230_CR55","doi-asserted-by":"publisher","first-page":"10568","DOI":"10.1073\/pnas.1105622108","volume":"108","author":"CI Hall","year":"2011","unstructured":"Hall, C. I. et al. Chemical genetic screen identifies Toxoplasma DJ-1 as a regulator of parasite secretion, attachment, and invasion. Proc. Natl. Acad. Sci. USA 108, 10568\u201310573. https:\/\/doi.org\/10.1073\/pnas.1105622108 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72230_CR56","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3389\/fmicb.2018.02587","volume":"9","author":"M Montazeri","year":"2018","unstructured":"Montazeri, M. et al. Drug resistance in Toxoplasma gondii. Front. Microbiol. 9, 2587. https:\/\/doi.org\/10.3389\/fmicb.2018.02587 (2018).","journal-title":"Front. Microbiol."},{"key":"72230_CR57","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1128\/aac.01203-07","volume":"52","author":"P Meneceur","year":"2008","unstructured":"Meneceur, P. et al. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone. Antimicrob. Agents Chemother. 52, 1269\u20131277. https:\/\/doi.org\/10.1128\/aac.01203-07 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"72230_CR58","doi-asserted-by":"publisher","first-page":"e0170689","DOI":"10.1371\/journal.pone.0170689","volume":"12","author":"LA Silva","year":"2017","unstructured":"Silva, L. A., Reis-Cunha, J. L., Bartholomeu, D. C. & Vitor, R. W. Genetic polymorphisms and phenotypic profiles of sulfadiazine-resistant and sensitive Toxoplasma gondii Isolates obtained from newborns with congenital toxoplasmosis in minas gerais Brazil. PLoS ONE 12, e0170689. https:\/\/doi.org\/10.1371\/journal.pone.0170689 (2017).","journal-title":"PLoS ONE"},{"key":"72230_CR59","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2174\/1574891x10666150410120321","volume":"9","author":"JC Sepulveda-Arias","year":"2014","unstructured":"Sepulveda-Arias, J. C., Veloza, L. A. & Mantilla-Muriel, L. E. Anti-Toxoplasma activity of natural products: a review. Recent Pat. Anti-Infect. Drug Discov. 9, 186\u2013194. https:\/\/doi.org\/10.2174\/1574891x10666150410120321 (2014).","journal-title":"Recent Pat. Anti-Infect. Drug Discov."},{"key":"72230_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jep.2008.08.007","volume":"120","author":"AO Santos","year":"2008","unstructured":"Santos, A. O. et al. Effect of Brazilian copaiba oils on Leishmania amazonensis. J. Ethnopharmacol. 120, 204\u2013208. https:\/\/doi.org\/10.1016\/j.jep.2008.08.007 (2008).","journal-title":"J. Ethnopharmacol."},{"key":"72230_CR61","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.exppara.2011.06.016","volume":"129","author":"AO dos Santos","year":"2011","unstructured":"dos Santos, A. O. et al. Leishmania amazonensis: effects of oral treatment with copaiba oil in mice. Exp. Parasitol. 129, 145\u2013151. https:\/\/doi.org\/10.1016\/j.exppara.2011.06.016 (2011).","journal-title":"Exp. Parasitol."},{"key":"72230_CR62","doi-asserted-by":"publisher","first-page":"898419","DOI":"10.1155\/2012\/898419","volume":"2012","author":"AO Dos Santos","year":"2012","unstructured":"Dos Santos, A. O., Ueda-Nakamura, T., Dias Filho, B. P., da Veiga Junior, V. F. & Nakamura, C. V. Copaiba oil: an alternative to development of new drugs against Leishmaniasis. Evid. Based Complement. Altern. Med. eCAM 2012, 898419. https:\/\/doi.org\/10.1155\/2012\/898419 (2012).","journal-title":"Evid. Based Complement. Altern. Med. eCAM"},{"key":"72230_CR63","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1590\/s0074-02762013000100010","volume":"108","author":"AO Santos","year":"2013","unstructured":"Santos, A. O. et al. Antileishmanial activity of diterpene acids in copaiba oil. Mem. Inst. Oswaldo Cruz 108, 59\u201364. https:\/\/doi.org\/10.1590\/s0074-02762013000100010 (2013).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"72230_CR64","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1021\/jm201451h","volume":"55","author":"E Izumi","year":"2012","unstructured":"Izumi, E., Ueda-Nakamura, T., Veiga, V. F. Jr., Pinto, A. C. & Nakamura, C. V. Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity. J. Med. Chem. 55, 2994\u20133001. https:\/\/doi.org\/10.1021\/jm201451h (2012).","journal-title":"J. Med. Chem."},{"key":"72230_CR65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.actatropica.2006.02.005","volume":"98","author":"SM Hernandez","year":"2006","unstructured":"Hernandez, S. M., Sanchez, M. S. & de Tarlovsky, M. N. Polyamines as a defense mechanism against lipoperoxidation in Trypanosoma cruzi. Acta Trop. 98, 94\u2013102. https:\/\/doi.org\/10.1016\/j.actatropica.2006.02.005 (2006).","journal-title":"Acta Trop."},{"key":"72230_CR66","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tcb.2007.07.009","volume":"17","author":"R Scherz-Shouval","year":"2007","unstructured":"Scherz-Shouval, R. & Elazar, Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 17, 422\u2013427. https:\/\/doi.org\/10.1016\/j.tcb.2007.07.009 (2007).","journal-title":"Trends Cell Biol."},{"key":"72230_CR67","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/ijms19051511","volume":"19","author":"R da Trindade","year":"2018","unstructured":"da Trindade, R. & da Silva, J. K. Copaifera of the neotropics: a review of the phytochemistry and pharmacology. Int. J. Mol. Sci. 19, 1511. https:\/\/doi.org\/10.3390\/ijms19051511 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"72230_CR68","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1128\/aac.01092-10","volume":"55","author":"MD Lavine","year":"2011","unstructured":"Lavine, M. D. & Arrizabalaga, G. The antibiotic monensin causes cell cycle disruption of Toxoplasma gondii mediated through the DNA repair enzyme TgMSH-1. Antimicrob. Agents Chemother. 55, 745\u2013755. https:\/\/doi.org\/10.1128\/aac.01092-10 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"72230_CR69","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1128\/aac.00455-11","volume":"55","author":"E Kamau","year":"2011","unstructured":"Kamau, E. et al. A novel benzodioxole-containing inhibitor of Toxoplasma gondii growth alters the parasite cell cycle. Antimicrob. Agents Chemother. 55, 5438\u20135451. https:\/\/doi.org\/10.1128\/aac.00455-11 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"72230_CR70","doi-asserted-by":"publisher","first-page":"22997","DOI":"10.1038\/srep22997","volume":"6","author":"RA Charvat","year":"2016","unstructured":"Charvat, R. A. & Arrizabalaga, G. Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function. Sci. Rep. 6, 22997. https:\/\/doi.org\/10.1038\/srep22997 (2016).","journal-title":"Sci. Rep."},{"key":"72230_CR71","doi-asserted-by":"publisher","first-page":"e42107","DOI":"10.1371\/journal.pone.0042107","volume":"7","author":"MD Lavine","year":"2012","unstructured":"Lavine, M. D. & Arrizabalaga, G. Analysis of monensin sensitivity in Toxoplasma gondii reveals autophagy as a mechanism for drug induced death. PLoS ONE 7, e42107. https:\/\/doi.org\/10.1371\/journal.pone.0042107 (2012).","journal-title":"PLoS ONE"},{"key":"72230_CR72","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.placenta.2012.12.006","volume":"34","author":"AS Castro","year":"2013","unstructured":"Castro, A. S. et al. Trophoblast cells are able to regulate monocyte activity to control Toxoplasma gondii infection. Placenta 34, 240\u2013247. https:\/\/doi.org\/10.1016\/j.placenta.2012.12.006 (2013).","journal-title":"Placenta"},{"key":"72230_CR73","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1095\/biolreprod.114.124115","volume":"92","author":"BF Barbosa","year":"2015","unstructured":"Barbosa, B. F. et al. IL10, TGF beta1, and IFN gamma modulate intracellular signaling pathways and cytokine production to control Toxoplasma gondii infection in BeWo trophoblast cells. Biol. Reprod. 92, 82. https:\/\/doi.org\/10.1095\/biolreprod.114.124115 (2015).","journal-title":"Biol. Reprod."},{"key":"72230_CR74","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2353\/ajpath.2008.070432","volume":"172","author":"EA Ferro","year":"2008","unstructured":"Ferro, E. A. et al. Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants. Am. J. Pathol. 172, 50\u201358. https:\/\/doi.org\/10.2353\/ajpath.2008.070432 (2008).","journal-title":"Am. J. Pathol."},{"key":"72230_CR75","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1096\/fj.08-111666","volume":"22","author":"M Flores","year":"2008","unstructured":"Flores, M. et al. Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 22, 3661\u20133671. https:\/\/doi.org\/10.1096\/fj.08-111666 (2008).","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"72230_CR76","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1016\/j.ajpath.2011.02.005","volume":"178","author":"GA de Oliveira","year":"2011","unstructured":"de Oliveira, G. A. et al. Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age. Am. J. Pathol. 178, 2792\u20132801. https:\/\/doi.org\/10.1016\/j.ajpath.2011.02.005 (2011).","journal-title":"Am. J. Pathol."},{"key":"72230_CR77","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.placenta.2013.12.013","volume":"35","author":"BF Barbosa","year":"2014","unstructured":"Barbosa, B. F. et al. Susceptibility to Toxoplasma gondii proliferation in BeWo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), via ERK1\/2 phosphorylation and prostaglandin E2 production. Placenta 35, 152\u2013162. https:\/\/doi.org\/10.1016\/j.placenta.2013.12.013 (2014).","journal-title":"Placenta"},{"issue":"Suppl 9A","key":"72230_CR78","doi-asserted-by":"publisher","first-page":"2s","DOI":"10.1016\/j.amjmed.2004.07.021","volume":"117","author":"BK Rubin","year":"2004","unstructured":"Rubin, B. K. Immunomodulatory properties of macrolides: overview and historical perspective. Am. J. Med. 117(Suppl 9A), 2s\u20134s. https:\/\/doi.org\/10.1016\/j.amjmed.2004.07.021 (2004).","journal-title":"Am. J. Med."},{"key":"72230_CR79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.parint.2007.01.008","volume":"56","author":"Y Shiono","year":"2007","unstructured":"Shiono, Y. et al. Maternal-fetal transmission of Toxoplasma gondii in interferon-gamma deficient pregnant mice. Parasitol. Int. 56, 141\u2013148. https:\/\/doi.org\/10.1016\/j.parint.2007.01.008 (2007).","journal-title":"Parasitol. Int."},{"key":"72230_CR80","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.placenta.2013.09.005","volume":"34","author":"MB Angeloni","year":"2013","unstructured":"Angeloni, M. B. et al. Differential apoptosis in BeWo cells after infection with highly (RH) or moderately (ME49) virulent strains of Toxoplasma gondii is related to the cytokine profile secreted, the death receptor Fas expression and phosphorylated ERK1\/2 expression. Placenta 34, 973\u2013982. https:\/\/doi.org\/10.1016\/j.placenta.2013.09.005 (2013).","journal-title":"Placenta"},{"key":"72230_CR81","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55\u201363 (1983).","journal-title":"J. Immunol. Methods"},{"key":"72230_CR82","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/ijms19010033","volume":"19","author":"FB Furtado","year":"2018","unstructured":"Furtado, F. B., Borges, B. C., Teixeira, T. L. & Garces, H. G. Chemical composition and bioactivity of essential oil from Blepharocalyx salicifolius. Int. J. Mol. Sci. 19, 33. https:\/\/doi.org\/10.3390\/ijms19010033 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"72230_CR83","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.placenta.2005.06.006","volume":"27","author":"JG Oliveira","year":"2006","unstructured":"Oliveira, J. G. et al. BeWo trophoblasts are unable to control replication of Toxoplasma gondii, even in the presence of exogenous IFN-gamma. Placenta 27, 691\u2013698. https:\/\/doi.org\/10.1016\/j.placenta.2005.06.006 (2006).","journal-title":"Placenta"},{"key":"72230_CR84","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.toxicon.2016.05.010","volume":"119","author":"IP Borges","year":"2016","unstructured":"Borges, I. P. et al. Anti-parasitic effect on Toxoplasma gondii induced by BnSP-7, a Lys49-phospholipase A2 homologue from Bothrops pauloensis venom. Toxicon Off. J. Int. Soc. Toxinol. 119, 84\u201391. https:\/\/doi.org\/10.1016\/j.toxicon.2016.05.010 (2016).","journal-title":"Toxicon Off. J. Int. Soc. Toxinol."},{"key":"72230_CR85","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1128\/aac.00868-12","volume":"56","author":"ET Kamau","year":"2012","unstructured":"Kamau, E. T. et al. A focused small-molecule screen identifies 14 compounds with distinct effects on Toxoplasma gondii. Antimicrob. Agents Chemother. 56, 5581\u20135590. https:\/\/doi.org\/10.1128\/aac.00868-12 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"72230_CR86","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/cbic.201900203","volume":"20","author":"S Cota Teixeira","year":"2019","unstructured":"Cota Teixeira, S. et al. Pentachloropseudilin impairs angiogenesis by disrupting the actin cytoskeleton, integrin trafficking and the cell cycle. ChemBioChem 20, 2390\u20132401. https:\/\/doi.org\/10.1002\/cbic.201900203 (2019).","journal-title":"ChemBioChem"},{"key":"72230_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.151904","author":"MA Dos Santos","year":"2020","unstructured":"Dos Santos, M. A. et al. Human B cells infected by Trypanosoma cruzi undergo F-actin disruption and cell death via caspase-7 activation and cleavage of phospholipase Cgamma1. Immunobiology https:\/\/doi.org\/10.1016\/j.imbio.2020.151904 (2020).","journal-title":"Immunobiology"},{"key":"72230_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinorgbio.2019.03.005","volume":"195","author":"MS Costa","year":"2019","unstructured":"Costa, M. S. et al. Increased ROS generation causes apoptosis-like death: mechanistic insights into the anti-Leishmania activity of a potent ruthenium(II) complex. J. Inorg. Biochem. 195, 1\u201312. https:\/\/doi.org\/10.1016\/j.jinorgbio.2019.03.005 (2019).","journal-title":"J. Inorg. Biochem."},{"key":"72230_CR89","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1210\/endo.138.9.5403","volume":"138","author":"I Caniggia","year":"1997","unstructured":"Caniggia, I., Lye, S. J. & Cross, J. C. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology 138, 3976\u20133986. https:\/\/doi.org\/10.1210\/endo.138.9.5403 (1997).","journal-title":"Endocrinology"},{"key":"72230_CR90","doi-asserted-by":"publisher","first-page":"814","DOI":"10.2174\/138920111795470976","volume":"12","author":"SS Vaidya","year":"2011","unstructured":"Vaidya, S. S., Walsh, S. W. & Gerk, P. M. Application of human placental villous tissue explants to study ABC transporter mediated efflux of 2,4-dinitrophenyl-S-glutathione. Curr. Pharm. Biotechnol. 12, 814\u2013823. https:\/\/doi.org\/10.2174\/138920111795470976 (2011).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"72230_CR91","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254 (1976).","journal-title":"Anal. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72230-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72230-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72230-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T11:21:55Z","timestamp":1696677715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72230-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72230"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72230-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15158"}}